Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
PepGen is empowering nucleic acid therapeutics to go the distance.
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
SiMa.ai is a developer of machine learning technology to deliver a software-centric platform.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Beckley Psytech is a biotechnology company developing psychedelic-based medicines for mental health conditions.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
ConnectRN is a tech-enabled network built to improve clinicians' lives through access to community, opportunity, and support.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Aptinyx Inc. is a biopharmaceutical company.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Pyramid Biosciences is a provider of biotechnological services.
Theseus Pharmaceuticals is a technology-based company.
Flame Biosciences is a clinical-stage company focused on therapies for cancer and other inflammatory diseases.
Adage Capital Management has invested in 76 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Adage Capital Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Medical. The firm invests across 22 different industry categories.
Among tracked funding rounds, Kailera Therapeutics received $600.0M in a Series B round. Adage Capital Management's total known invested capital is $11.1B.
Adage Capital Management's average investment size is $160.5M across its portfolio of 76 companies.
Recent Adage Capital Management portfolio additions include Kailera Therapeutics, Spyre Therapeutics, Cidara Therapeutics, Pepgen, Arvinas. These companies were founded in 2020 or later.